SEC Form 4 · accession 0001437749-16-035864
CESCA THERAPEUTICS INC. · KOOL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robin C Stracey
Officer — CEO · Director
Period of report
Jul 26, 2016
Accepted (ET)
Jul 28, 2016 · 3:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000811212
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jul 26, 2016 | A | 29,720 | $0.00 | A | 116,676 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents 29,720 shares of restricted common stock that vest on July 1, 2017.
- F2Also represents 50, 000 shares of restricted stock units which vest in 4 equal installments based upon a combination of time and milestone based targets.